Therapy of gastroesophageal reflux disease and functional dyspepsia overlaps with symptoms after usual‐dose proton pump inhibitor: Acotiamide plus usual‐dose proton pump inhibitor versus double‐dose proton pump inhibitor

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1746|33|3|623-630

ISSN： 0815-9319

Source： JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol.33, Iss.3, 2018-03, pp. : 623-630

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inappropriate Proton Pump Inhibitor Prescription in Elderly Adults: As Usual As Dangerous

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 63, Iss. 10, 2015-10 ,pp. : 2198-2199

John Wiley & Sons Inc

Access to resources Recommend Favorite

Proton Pump Inhibitor Therapy and Osteoporosis

By  

Current Drug Safety, Vol. 3, Iss. 3, 2008-01 ,pp. : 204-209

Bentham Science Publishers

Access to resources Recommend Favorite

Abnormal esophageal acid exposure on high‐dose proton pump inhibitor therapy is common in systemic sclerosis patients

By  

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 30, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Using prophylactic proton pump inhibitor

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 3, 2015-03 ,pp. : 478-484

John Wiley & Sons Inc

Access to resources Recommend Favorite

Proton Pump Inhibitor Improves Breath Marker in Moderate Asthma with Gastroesophageal Reflux Disease

By  

Respiration, Vol. 74, Iss. 5, 2007-03 ,pp. : 558-564

Karger

Access to resources Recommend Favorite